Discussion on a safe approach to creating humorous ads for Premium brands: A thematic analysis

The concept of humorous ads has been extensively applied by numerous brands and the results have often been impactful and advantageous for their business. However, when it comes to premium brands, indecisiveness still remains. Many premium brands avoid the use of humor in their ads so as to maintain their elegance. Others, however, have taken a risk and have been experimenting with this unknown substance. The research aims to identify a safe approach that would help premium brands use humor in their ads while keeping their prestige and elegance intact. The study derives four themes which are brand recall, brand perception, purchase intention, and critical elements for creating humorous ads for premium brands. While humor had positive impact on brand recall and brand perception, it was indifferent to the buying behavior of respondents. The study found that appropriate messages, the use of public figures, and relevant ad messages were the key factors that would help premium brands

Enactment of Sustainable Technovations on Healthcare Sectors

This article discusses the use of innovative technologies and their potential to assist pan-India surveillance systems, including health  initiatives. The key goal is to review prior studies on innovative technology and its use for existing healthcare sectors and identify association strength among the selected variables using Vos Viewer software. Information gathered from research on randomized controlled trials, cross-sectional studies, review studies and systematic review studies, meta-analysis, sample, and case series. This article discusses the use of innovative technologies and their potential to assist pan-India surveillance systems, including health  initiatives to community based healthcare. This paper discusses the current usage of Artificial Intelligence, Blockchain, and the Internet of Things (IoT) on health and developments.   The findings of the study state the complexities and opportunities of the mentioned technologies on the pan-India health surveillance system and indicates that data management, safety and security regulation gaps need to resolve before enforcing monitoring practices. This paper presents an analysis of recent instances of using IoT technologies centred on remote surveillance and indicate a need for an advanced computing architecture for future integrated with pilot and tracking operations

Health-status outcomes with invasive or conservative care in coronary disease

BACKGROUND In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients. METHODS We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency. RESULTS At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina). CONCLUSIONS In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline

Initial invasive or conservative strategy for stable coronary disease

BACKGROUND Among patients with stable coronary disease and moderate or severe ischemia, whether clinical outcomes are better in those who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain. METHODS We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial conservative strategy of medical therapy alone and angiography if medical therapy failed. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. A key secondary outcome was death from cardiovascular causes or myocardial infarction. RESULTS Over a median of 3.2 years, 318 primary outcome events occurred in the invasive-strategy group and 352 occurred in the conservative-strategy group. At 6 months, the cumulative event rate was 5.3% in the invasive-strategy group and 3.4% in the conservative-strategy group (difference, 1.9 percentage points; 95% confidence interval [CI], 0.8 to 3.0); at 5 years, the cumulative event rate was 16.4% and 18.2%, respectively (difference, 121.8 percentage points; 95% CI, 124.7 to 1.0). Results were similar with respect to the key secondary outcome. The incidence of the primary outcome was sensitive to the definition of myocardial infarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical importance. There were 145 deaths in the invasive-strategy group and 144 deaths in the conservative-strategy group (hazard ratio, 1.05; 95% CI, 0.83 to 1.32). CONCLUSIONS Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years. The trial findings were sensitive to the definition of myocardial infarction that was used